Back to news
BUSINESSThe Marijuana Herald

New York approves cannabis research license for U.S. VER-01 pain trial

New York approved Upstate Clinical Research Associates to participate in a placebo-controlled U.S. trial of VER-01, an oral THC medicine for chronic painful sciatica that has not responded to non-opioid treatment. The project shows Oklahoma researchers and medical operators the licensing, product-standardization and evidence requirements involved in moving a cannabis formulation toward regulated medicine.

Share this update

FacebookXLinkedInEmail

#other-state#new-york#research#medical-cannabis#licensing

Read the original source

Leafy summaries provide industry context. Confirm details with The Marijuana Herald.

Open source

Continue reading

Related industry updates